# Remifentanil Versus Propofol for TCI Sedation of Patients Undergoing Gastrointestinal Endoscopic Procedures

> **NCT01746641** · PHASE4 · TERMINATED · sponsor: **Fundación Universitaria de Ciencias de la Salud** · enrollment: 69 (actual)

## Conditions studied

- Pain

## Interventions

- **DRUG:** Remifentanil
- **DRUG:** Propofol

## Key facts

- **NCT ID:** NCT01746641
- **Lead sponsor:** Fundación Universitaria de Ciencias de la Salud
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2010-01
- **Primary completion:** 2010-06
- **Final completion:** 2010-06
- **Target enrollment:** 69 (ACTUAL)
- **Why stopped:** Occurrence of severe respiratory depression in the remifentanil group.
- **Last updated:** 2012-12-11

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01746641

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01746641, "Remifentanil Versus Propofol for TCI Sedation of Patients Undergoing Gastrointestinal Endoscopic Procedures". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT01746641. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*